DT Investment Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $284K | Hold |
2,040
| – | – | 0.02% | 125 |
|
|
2025
Q4 | $250K | Buy |
2,040
+100
| +5% | +$12.2K | 0.02% | 133 |
|
|
2025
Q3 | $215K | Hold |
1,940
| – | – | 0.02% | 137 |
|
|
2025
Q2 | $215K | Buy |
1,940
+100
| +5% | +$10.6K | 0.02% | 145 |
|
|
2025
Q1 | $206K | Hold |
1,840
| – | – | 0.02% | 143 |
|
|
2024
Q4 | $170K | Hold |
1,840
| – | – | 0.01% | 156 |
|
|
2024
Q3 | $154K | Hold |
1,840
| – | – | 0.01% | 167 |
|
|
2024
Q2 | $126K | Hold |
1,840
| – | – | 0.01% | 168 |
|
|
2024
Q1 | $135K | Hold |
1,840
| – | – | 0.01% | 155 |
|
|
2023
Q4 | $145K | Sell |
1,840
-125
| -6% | -$9.73K | 0.02% | 149 |
|
|
2023
Q3 | $147K | Sell |
1,965
-15,187
| -89% | -$1.17M | 0.02% | 135 |
|
|
2023
Q2 | $1.3M | Sell |
17,152
-32
| -0.2% | -$2.55K | 0.15% | 64 |
|
|
2023
Q1 | $1.4M | Buy |
17,184
+181
| +1% | +$15K | 0.17% | 57 |
|
|
2022
Q4 | $1.46M | Sell |
17,003
-177
| -1% | -$14K | 0.19% | 60 |
|
|
2022
Q3 | $1.06M | Sell |
17,180
-584
| -3% | -$36.8K | 0.17% | 61 |
|
|
2022
Q2 | $1.1M | Buy |
17,764
+524
| +3% | +$32.4K | 0.16% | 68 |
|
|
2022
Q1 | $1.02M | Buy |
17,240
+2,186
| +15% | +$140K | 0.13% | 83 |
|
|
2021
Q4 | $1.09M | Sell |
15,054
-911
| -6% | -$62.7K | 0.14% | 73 |
|
|
2021
Q3 | $1.11M | Buy |
15,965
+2,989
| +23% | +$210K | 0.15% | 70 |
|
|
2021
Q2 | $893K | Buy |
12,976
+972
| +8% | +$64.9K | 0.12% | 81 |
|
|
2021
Q1 | $776K | Buy |
12,004
+313
| +3% | +$20.2K | 0.11% | 86 |
|
|
2020
Q4 | $681K | Sell |
11,691
-1,824
| -13% | -$110K | 0.11% | 85 |
|
|
2020
Q3 | $854K | Sell |
13,515
-950
| -7% | -$65.9K | 0.12% | 69 |
|
|
2020
Q2 | $1.11M | Buy |
14,465
+3,938
| +37% | +$302K | 0.14% | 54 |
|
|
2020
Q1 | $787K | Sell |
10,527
-46,909
| -82% | -$3.24M | 0.13% | 62 |
|
|
2019
Q4 | $3.73M | Buy |
57,436
+3,689
| +7% | +$240K | 0.34% | 60 |
|
|
2019
Q3 | $3.41M | Buy |
53,747
+3,124
| +6% | +$204K | 0.44% | 48 |
|
|
2019
Q2 | $3.42M | Buy |
50,623
+3,113
| +7% | +$205K | 0.47% | 44 |
|
|
2019
Q1 | $3.09M | Buy |
47,510
+1,903
| +4% | +$126K | 0.43% | 45 |
|
|
2018
Q4 | $2.85M | Buy |
45,607
+386
| +0.9% | +$27K | 0.46% | 44 |
|
|
2018
Q3 | $3.49M | Buy |
45,221
+3,721
| +9% | +$281K | 0.5% | 41 |
|
|
2018
Q2 | $2.94M | Buy |
41,500
+5,203
| +14% | +$367K | 0.45% | 45 |
|
|
2018
Q1 | $2.74M | Buy |
36,297
+2,672
| +8% | +$212K | 0.42% | 44 |
|
|
2017
Q4 | $2.41M | Buy |
33,625
+5,276
| +19% | +$401K | 0.38% | 47 |
|
|
2017
Q3 | $2.3M | Buy |
28,349
+9,310
| +49% | +$712K | 0.39% | 40 |
|
|
2017
Q2 | $1.35M | Buy |
19,039
+2,869
| +18% | +$191K | 0.26% | 41 |
|
|
2017
Q1 | $1.1M | Buy |
+16,170
| New | +$1.14M | 0.25% | 40 |
|
Other funds holding GILD
VCM
VPM
DT Investment Partners's GILD Position: Q1 2026 in Review
DT Investment Partners held its Gilead Sciences (GILD) position steady in Q1 2026 at 2,040 shares worth $284K. The position accounts for 0.02% of the portfolio, ranked #125.
DT Investment Partners first reported a position in GILD in Q1 2017 and has held it in 37 quarters since. The position peaked at $3.73M in Q4 2019. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- DT Investment Partners held 2,040 shares of Gilead Sciences worth $284K as of Q1 2026.
- DT Investment Partners left its Gilead Sciences share count unchanged in Q1 2026.
- Gilead Sciences made up 0.02% of DT Investment Partners's portfolio in Q1 2026, its #125 holding.
- DT Investment Partners first reported a position in Gilead Sciences in Q1 2017 and has held it in 37 quarters since.
- DT Investment Partners's Gilead Sciences position peaked at $3.73M in Q4 2019.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on DT Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.